Esthesioneuroblastoma

Get in touch with RARE Concierge.

Contact RARE Concierge

Esthesioneuroblastoma

Synonyms: Olfactory neuroblastoma

Esthesioneuroblastoma (ENB) is a rare malignant neoplasm of the sinonasal cavity arising from the basal layers of olfactory neuroepithelial cells in the superior nasal vault which usually occurs in the 5th to 6th decades of life and is characterized clinically by non-specific symptoms such as progressive ipsilateral nasal block sinusitis facial pain intermittent headaches hyposmia/dysosmia rhinorrhea and epistaxis as well as proptosis diplopia and excessive lacrimation due to orbital extension. With early treatment and in the absence of distant metastases ENB appears to have a good prognosis (compared to other superior nasal malignancies) despite a high rate of cervical metastases.

Data from Orphanet are used to provide information on a disease's name, synonym(s), and overview.

Reference: Access aggregated data from Orphanet at Orphadata.

Orphadata: Free access data from Orphanet. © INSERM 1999. Available on http://www.orphadata.org. Data version April 2024

Newly diagnosed with
Esthesioneuroblastoma?

Our RARE Concierge Services Guides are available to assist you by providing information, resources and connections as you navigate your rare disease journey.

Get Concierge Help

Advocacy Organizations

My Faulty Gene

My Faulty Gene is a nonprofit organization which provides information and assistance to any individual whose family medical history suggests genetic testing might be helpful in identifying an increased risk of disease due to a genetic mutation. We believe that everyone in need of genetic testing should have access to it.

My Little Sunshine Foundation

My Little Sunshine is a non-profit foundation dedicated to educating people about the importance of fertility preservation and making fertility resources accessible to all.

SALUS

Educate and provide resources to POC with Rare Cancers

Clinical Trials

For a list of clinical trials in this disease area, please click here.